Enzo Biochem Inc. ($0.01 Par Value) (ENZ) Financials

$0.54

$0.00 (-0.02%)

As on 18-Jun-2025 09:30EDT

Market cap

$16 Mln

Revenue (TTM)

$27 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

125 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Operating Revenue	27.48	31.91	31.06	107.07	117.73	76.02
Cost of Revenue	15.45	17.28	19.50	65.10	64.15	52.25
Gross Profit	12.02	14.63	11.57	41.97	53.58	23.77
Operating Expenses	23.19	24.37	31.11	57.47	48.16	47.41
Operating Profit (EBIT)	-10.73	-9.82	-24.74	-15.51	9.88	-23.64
Other Income	--	--	--	-3.25	--	1.39
Profit before Tax	-7.84	-9.82	-25.02	-18.26	7.88	-28.52
Provision for Tax	13.24	16.26	12.30	4.32	4.45	5.37
Profit after Tax (Net Income)	-21.08	-26.08	20.29	-22.58	3.43	-33.89
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	20.29	-18.26	7.88	-28.52

Liabilities ($ Mln)	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Shareholder's Funds	43.40	56.11	78.46	54.46	68.59	58.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.11	4.86	3.43	16.85	19.03	21.36
Current Liabilities	17.01	24.79	39.99	24.55	26.08	32.80
Total Liabilities	80.53	85.76	121.88	95.86	113.69	112.54

Assets ($ Mln)	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Non-Current Assets	15.24	15.73	23.42	41.50	43.11	43.77
Current Assets	48.28	70.03	98.46	54.35	70.58	68.77
Total Assets	80.53	85.76	121.88	95.86	113.69	112.54
Total Debt*	3.00	3.51	7.00	20.59	22.68	32.79
Net Current Assets	31.27	45.24	58.47	29.80	44.51	35.96

Cashflow ($ Mln)	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Cash From Operating Activities	--	-26.26	-36.98	-16.59	0.39	-17.18
Cash Flow from Investing Activities	--	--	98.98	25.22	-34.50	-2.17
Cash from Financing Activities	--	-4.19	-1.13	-0.24	-0.24	7.00
Net Cash Inflow / Outflow	--	--	--	8.39	--	-12.28

Financials Ratios	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
ROCE (%)	--	-35.95	25.28	-27.15	3.75	-37.20
ROE (%)	-46.31	-38.76	30.53	-36.70	5.40	-46.94
ROA (%)	-21.55	-25.12	18.64	-21.55	3.03	-30.92
EBIT Margin (%)	-29.39	-30.15	-76.05	-16.66	0.59	-39.95
Net Margin (%)	-76.73	-81.73	65.32	-21.75	2.91	-43.78
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Revenue Growth (%)	-50.44	0.03	-0.71	-0.09	0.55	-0.06
EBIT Growth (%)	-17.34	59.28	-32.46	-2,677.17	102.28	-11.68
Net Profit Growth (%)	-377.72	-228.54	189.86	-759.21	110.11	65.69
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.65	--	--	--	--	--
Dividend Yield (%)	125.00	--	--	--	--	--
EV/EBITDA	-3.27	6.45	3.60	0.07	-6.23	0.55
Close Price ($)	0.48	1.14	1.48	2.37	3.26	2.38
High Price ($)	1.28	1.71	2.75	4.15	4.85	4.85
Low Price ($)	0.25	0.99	1.00	1.98	1.80	1.56
Market Cap ($ Cr)	16.44	--	--	--	--	--

Solvency Ratios	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Debt to Equity	0.00	0.06	0.09	0.38	0.33	0.56
Short term debt to equity ratio	0.02	0.02	0.02	0.02	0.10	0.27
Current Ratio	2.84	2.82	2.46	2.21	2.71	2.10
Quick Ratio	2.50	2.55	2.26	1.59	2.22	1.86
Interest Coverage	-38.80	-48.83	-16.89	-112.16	86.50	-66.89

Operating Efficiency Ratios	TTM	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15
Debtors to sales (%)	15.68	12.50	15.48	4.45	8.66	12.02
Asset Turnover	0.28	0.31	0.29	1.02	1.04	0.69
Receivable days	--	50.35	56.27	25.52	30.00	47.76
Inventory Days	--	156.15	218.74	78.72	58.17	54.62
Payable days	--	52.34	68.29	33.21	47.33	55.08
Cash Conversion Cycle	--	154.16	206.71	71.03	40.84	47.29

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.